Bioheart (BHRT) Announces CE Marking for TGI 1200(tm) Adult Stem Cell Isolation System
Bioheart, Inc. (Nasdaq: BHRT) announced that CE mark has been applied to the TGI 1200 System in order to begin marketing the TGI 1200 System in all countries recognizing the CE mark. The TGI 1200 System is a fully automated cell isolation system that recovers potentially regenerative cells from a patient's own adipose (fat) tissue in about an hour, with minimal operator intervention. The system accepts adipose tissue from the same device used for liposuctioning the tissue from the patient. The compact desktop unit readily fits into any clinical environment and uses preconfigured disposables for quick and easy assembly. The CE marking confirms that the device has met essential health and safety requirements, as well as environmental and consumer protection legislation within Europe. Bioheart expects to deliver five TGI 1200 Systems for its European customers by the end of the year.
You May Also Be Interested In
- Pfizer (PFE) Axitinib Gets Positive Opinion from CHMP EMA
- Baird Reiterates a 'Neutral' on Onyx Pharmaceuticals (ONXX); Nexavar Miss Not Real Issue; Kyprolis Remains Focus
- Mylan (MYL) Launches Generic Bonviva Tabs (RHHBY) in Italy & the U.K.
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
